Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTZ in Acute Decompensation of Liver Cirrhosis or ACLF
NCT07694297Phase 2Not yet recruiting
- Sponsor
- Genfit
- Start
- Oct 2026
- Primary completion
- Aug 2027
01
Overview
A Phase 2 trial of nitazoxanide in Liver cirrhosis (LC), acute-on-chronic liver failure (ACLF), sponsored by Genfit. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
nitazoxanide
03
Conditions
Liver cirrhosis (LC)acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT07694297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07694297.